ALX1-11 recombinant human parathyroid hormone: Will begin in early May a U.S. and Canadian Phase II trial of three dose levels and placebo to see the effect on

Allelix Biopharmaceuticals Inc. (TSE:AXB), Toronto Product: ALX1-11 recombinant human parathyroid hormone Indication: Osteoporosis Status: Will begin in early May a U.S. and Canadian Phase II trial ...